Top compounds associated with response to KRTAP12-4


Feature Type Standardized
Nominal ANOVA
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.11 0.0008
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC 0.18 0.001
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA alisertib CTRPv2 pan-cancer AAC 0.1 0.001
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.002
Download CSV